Tevogen Inc.
Public company- Headquarters
- WARREN, New Jersey
- Industry
- Biotechnology
- Ticker
- TVGN
- CIK
- 0001860871
WARN notices since 2024
Workers affected since 2024
Executive changes, last 12 months
Last event
Workers affected over time
Cumulative workers in WARN notices since 2024
Not enough notices to chart yet.
Leadership
| Role and person | Since | Change |
|---|---|---|
| directorSusan Podlogar | Nov 4, 2026 | Departed |
| Class II directorKeow Lin Goh | Aug 26, 2026 | Appointed |
Related companies
Same industry and state, with recent events.
- Outlook Therapeutics, Inc.
CFO appointed: Kevin Lundquist
- ANAVEX LIFE SCIENCES CORP.
CEO appointed: Terrie Kellmeyer, Ph.D.
- RECURSION PHARMACEUTICALS, INC.
Chair of the Board appointed: Fred Hassan
- Vir Biotechnology, Inc.
Class III director appointed: Suzanne Topalian, M.D.
- Executive departure
director departs: Susan Podlogar
Susan Podlogar, director of Tevogen Inc., resigns the role, effective November 2, 2026. The company reported the change in an 8-K that cites Item 5.02.
Source: SEC 8-K, filed Nov 4, 2026Role: director
- Executive appointment
Class II director appointed: Keow Lin Goh
Keow Lin Goh was named Class II director of Tevogen Inc., effective August 24, 2026. The company reported the change in an 8-K that cites Item 5.02.
Source: SEC 8-K, filed Aug 26, 2026Role: Class II director
- Executive appointment
Class II director appointed: Victor Sordillo
Victor Sordillo was named Class II director of Tevogen Inc., effective August 24, 2026. The company reported the change in an 8-K that cites Item 5.02.
Source: SEC 8-K, filed Aug 26, 2026Role: Class II director
Last verified Nov 8, 2026